The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

BACKGROUND: Valproate is widely accepted as a drug of first choice for patients with generalised onset seizures, and its broad spectrum of efficacy means it is recommended for patients with seizures that are difficult to classify. Lamotrigine and topiramate are also thought to possess broad spectrum...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Marson, Anthony G, Al-Kharusi, Asya M, Alwaidh, Muna, Appleton, Richard, Baker, Gus A, Chadwick, David W, Cramp, Celia, Cockerell, Oliver C, Cooper, Paul N, Doughty, Julie, Eaton, Barbara, Gamble, Carrol, Goulding, Peter J, Howell, Stephen J L, Hughes, Adrian, Jackson, Margaret, Jacoby, Ann, Kellett, Mark, Lawson, Geoffrey R, Leach, John Paul, Nicolaides, Paola, Roberts, Richard, Shackley, Phil, Shen, Jing, Smith, David F, Smith, Philip E M, Smith, Catrin Tudur, Vanoli, Alessandr a, Williamson, Paula R
Formato: Artigo
Idioma:Inglês
Publicado: 2007
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2039891/
https://ncbi.nlm.nih.gov/pubmed/17382828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(07)60461-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares